Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1.
Oncol Lett
; 10(4): 2359-2365, 2015 Oct.
Article
en En
| MEDLINE
| ID: mdl-26622852
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
Idioma:
En
Revista:
Oncol Lett
Año:
2015
Tipo del documento:
Article